The overexpression of SIGIRR in RCC cells attenuated IL1-induced NFKBIZ activation, with a trend of effect on IL6, PD-L1, and ICAM1 induction, suggesting that SIGIRR manipulation may be beneficial to block IL1 in kidney cancer. Here, ICAM1 is linked to kidney cancer.